Correspondence 0001683168-23-008995 from CNS Pharmaceuticals, Inc. (CNSP)

CNS Pharmaceuticals, Inc.
Date: Dec. 20, 2023 · CIK: 0001729427 · Accession: 0001683168-23-008995

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-275973

Date

December 15, 2023

Author

Managing Director

Form

CORRESP

Company

CNS Pharmaceuticals, Inc.

Letter

A.G.P./Alliance Global Partners

590 Madison Ave., 28th Floor

New York, NY 10022

December 20,

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Re: CNS Pharmaceuticals Inc. (the “Company”)

Registration Statement on Form S-1 (File No. 333-275973) (the “Registration Statement”)

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on December 15, 2023, in which A.G.P / Alliance Global Partners as lead Placement Agent, joined the Company’s request for acceleration of the effective date of the above-referenced Registration Statement for 5:00 pm Eastern Time on December 18, 2023, or as soon thereafter as practicable, in accordance with Rule 461 under the Securities Act of 1933, as amended. The Company is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

Very truly yours,
A.G.P / Alliance Global Partners

Show Raw Text

CORRESP
1
filename1.htm

A.G.P./Alliance Global Partners

590 Madison Ave., 28th Floor

New York, NY 10022

December 20,
2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

    Re:
    CNS Pharmaceuticals Inc. (the “Company”)

    Registration Statement on Form S-1 (File No. 333-275973) (the “Registration Statement”)

Ladies and Gentlemen:

Reference is made to our letter,
filed as correspondence via EDGAR on December 15, 2023, in which A.G.P / Alliance Global Partners as lead Placement Agent, joined the
Company’s request for acceleration of the effective date of the above-referenced Registration Statement for 5:00 pm Eastern Time
on December 18, 2023, or as soon thereafter as practicable, in accordance with Rule 461 under the Securities Act of 1933, as amended.
The Company is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw
our request for acceleration of the effective date.

    Very truly yours,

    A.G.P / Alliance Global Partners

    By:
    /s/ Thomas J. Higgins

    Name:
    Thomas J. Higgins

    Title:
    Managing Director

SecProbe.io